CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multicenter study.

Research output: Contribution to journalArticle

Abstract

The aim of this study was to test the diagnostic value of cerebrospinal fluid (CSF) beta-amyloid (Aβ1-42), phosphorylated tau, and total tau (tau) to discriminate Alzheimer's disease (AD) dementia from other forms of dementia.

Details

Authors
  • Michael Ewers
  • Niklas Mattsson
  • Lennart Minthon
  • José L Molinuevo
  • Anna Antonell
  • Julius Popp
  • Frank Jessen
  • Sanna-Kaisa Herukka
  • Hilka Soininen
  • Walter Maetzler
  • Thomas Leyhe
  • Katharina Bürger
  • Miyako Taniguchi
  • Katsuya Urakami
  • Simone Lista
  • Bruno Dubois
  • Kaj Blennow
  • Harald Hampel
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology
Original languageEnglish
Pages (from-to)1306-1315
JournalAlzheimer's & Dementia
Volume11
Issue number11
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes